AR and neuromuscular disease: The resulting line of ‘BAC fxAR121’ mice were then crossed with human-skeletal actin (HSA) Cre-recombinase transgenic mice to derive BAC fxAR121; HSA-Cre bigenic mice lacking expression of polyQ-AR in skeletal muscle, which was sufficient to prevent onset of neuromuscular disease and early death [4].